EBQ:PEITHO Trial: Difference between revisions
Ostermayer (talk | contribs) (Created page with "{{JC info | title= Fibrinolysis for patients with intermediate-risk pulmonary embolism | abbreviation= PEITHO | expansion= Pulmonary Embolism Thrombolysis Trial | published= ...") |
Ostermayer (talk | contribs) No edit summary |
||
| Line 12: | Line 12: | ||
| pmid= 24716681 | | pmid= 24716681 | ||
| fulltexturl= http://www.nejm.org/doi/full/10.1056/NEJMoa1302097 | | fulltexturl= http://www.nejm.org/doi/full/10.1056/NEJMoa1302097 | ||
| pdfurl=http:// | | pdfurl=http://theddx.org/papers/PEITHO.pdf | ||
}} | }} | ||
==Clinical Question== | ==Clinical Question== | ||
Revision as of 19:01, 7 September 2014
incomplete Journal Club Article
Meyer G. et al.. "Fibrinolysis for patients with intermediate-risk pulmonary embolism". NEJM. 2014. 10(370):1402-1411.
PubMed Full text PDF
PubMed Full text PDF
Clinical Question
Does thrombolysis with tenecteplase reduce mortality or hemodynamic collapse in patients with sub-massive PE at 7 days compared to placebo?